Iran J Med Sci:HA/ZrO2和PRP的修复恢复骨缺损

2019-10-15 不详 网络

富含血小板的血浆(PRP)和生物陶瓷,例如羟基磷灰石(HA)和氧化锆(ZrO2)用于重建下颌骨缺损。我们试图确定HA/ZrO2和PRP的协同作用,并比较它们的成骨活性。通过淤浆法构建ZrO2支架,然后用HA涂覆并用PRP/硫酸乙酰肝素(HS)浸渍。在26只雄性兔子的双侧下颌制造缺损。在20只兔中,用HA/ZrO2/PRP(第1组)治疗左缺损,用HA/ZrO2(第2组)填充相应的右缺损。其余6个模型

富含血小板的血浆(PRP)和生物陶瓷,例如羟基磷灰石(HA)和氧化锆(ZrO2)用于重建下颌骨缺损。我们试图确定HA/ZrO2和PRP的协同作用,并比较它们的成骨活性。

通过淤浆法构建ZrO2支架,然后用HA涂覆并用PRP/硫酸乙酰肝素(HS)浸渍。在26只雄性兔子的双侧下颌制造缺损。在20只兔中,用HA/ZrO2/PRP(第1组)治疗左缺损,用HA/ZrO2(第2组)填充相应的右缺损。其余6个模型在两侧均用PRP凝胶处理(第3组)。在随访期的第2、6和8周,通过放射学和组织学方法对比HA/ZrO2/PRP与HA/ZrO2或PRP的骨电导率。

结果显示,2周后,经HA/ZrO2/PRP处理的缺损比被PRP处理的缺损占骨表面的百分比明显更高(P = 0.007)。PRP治疗组的成骨细胞和骨细胞计数明显更高(P = 0.032);然而,这些细胞尚未大规模开始形成基质,仅观察到了小类的类骨质蛋白及其中的骨细胞。从长远来看,所有支架的再生潜力是相同的。

总之,该研究结果表明,在短期内,HA/ZrO2的骨传导能力优于PRP。但是,它们没有显示出长期的协同作用。

原始出处:

Shahsavari-Pour S, Aliabadi E, et al., Evaluation of the Possible Synergic Regenerative Effects of Platelet-Rich Plasma and Hydroxyapatite/Zirconia in the Rabbit Mandible Defect Model. Iran J Med Sci. 2018 Nov;43(6):633-644.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1958335, encodeId=bf7d1958335ef, content=<a href='/topic/show?id=3f5514e764a' target=_blank style='color:#2F92EE;'>#PRP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14776, encryptionId=3f5514e764a, topicName=PRP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Mon May 11 13:19:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419337, encodeId=6629141933ece, content=<a href='/topic/show?id=2e2e10182602' target=_blank style='color:#2F92EE;'>#骨缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101826, encryptionId=2e2e10182602, topicName=骨缺损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51173492599, createdName=lfcmxl, createdTime=Thu Oct 17 11:19:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610032, encodeId=300516100320a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 17 11:19:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1958335, encodeId=bf7d1958335ef, content=<a href='/topic/show?id=3f5514e764a' target=_blank style='color:#2F92EE;'>#PRP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14776, encryptionId=3f5514e764a, topicName=PRP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Mon May 11 13:19:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419337, encodeId=6629141933ece, content=<a href='/topic/show?id=2e2e10182602' target=_blank style='color:#2F92EE;'>#骨缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101826, encryptionId=2e2e10182602, topicName=骨缺损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51173492599, createdName=lfcmxl, createdTime=Thu Oct 17 11:19:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610032, encodeId=300516100320a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 17 11:19:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]
    2019-10-17 lfcmxl
  3. [GetPortalCommentsPageByObjectIdResponse(id=1958335, encodeId=bf7d1958335ef, content=<a href='/topic/show?id=3f5514e764a' target=_blank style='color:#2F92EE;'>#PRP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14776, encryptionId=3f5514e764a, topicName=PRP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f00658, createdName=yyanpro@21cn.c, createdTime=Mon May 11 13:19:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1419337, encodeId=6629141933ece, content=<a href='/topic/show?id=2e2e10182602' target=_blank style='color:#2F92EE;'>#骨缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101826, encryptionId=2e2e10182602, topicName=骨缺损)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51173492599, createdName=lfcmxl, createdTime=Thu Oct 17 11:19:00 CST 2019, time=2019-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610032, encodeId=300516100320a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 17 11:19:00 CST 2019, time=2019-10-17, status=1, ipAttribution=)]